WALDENSTROM MACROGLOBULINAEMIA

Clinical trials for WALDENSTROM MACROGLOBULINAEMIA explained in plain language.

Never miss a new study

Get alerted when new WALDENSTROM MACROGLOBULINAEMIA trials appear

Sign up with your email to follow new studies for WALDENSTROM MACROGLOBULINAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Could less medicine be better? major trial tests lower doses for blood cancers

Disease control Not yet recruiting

This large trial aims to find the best dose for blood cancer drugs, testing if lower doses can control the disease just as well while causing fewer side effects. It will enroll 400 adults with conditions like multiple myeloma and Waldenstrom's macroglobulinemia. The study uses a …

Matched conditions: WALDENSTROM MACROGLOBULINAEMIA

Phase: PHASE4 • Sponsor: Anne Louise Tølbøll Sørensen • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

WALDENSTROM MACROGLOBULINAEMIA

Get alerted when new WALDENSTROM MACROGLOBULINAEMIA trials appear

Could less medicine be better? major trial tests lower doses for blood cancers